SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 is experiencing heightened volatility as investors weigh sharp declines in major technology stocks against shifting geopolitical developments and uncertainty regarding Federal Reserve interest rate policy. Community sentiment is deeply polarized, with active debates centered on whether this market environment represents a healthy rotation into value sectors or the beginning of a broader correction driven by unsustainable valuation levels.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is seeing intense investor focus as it nears earnings, driven by a surge in demand for AI-critical memory and a strategic infrastructure agreement with Anthropic. The community is actively debating whether the stock's massive rally is a sustainable re-rating based on structural AI demand or an overextended bubble primed for a post-earnings pullback.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk Corp (SNDK) is witnessing a parabolic rally driven by an AI-induced memory supercycle and persistent NAND supply shortages that investors believe will last for years. While the stock has reached extreme valuations, the community remains sharply divided between bulls chasing the intense momentum and bears anticipating a massive rug pull due to the lack of significant pullbacks.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending as traders closely watch a divergence between semiconductor strength and significant volatility in other major tech names, alongside concerns regarding liquidity and geopolitical risks. The community is actively debating whether current price action signals a healthy rotation or a deeper structural correction as market participants navigate overnight volatility and uncertain macroeconomic signals.

Roundhill ETF Trust - Roundhill Memory ETF

Roundhill Memory ETF ($DRAM) is trending as investors aggressively position into memory and storage infrastructure, viewing it as a critical bottleneck for AI scaling rather than a typical cyclical semiconductor play. The community is focused on the sector's long-term supply constraints and pricing power, with many traders actively accumulating positions in anticipation of upcoming major earnings reports and potential structural re-ratings within the broader AI supply chain.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is trending as investors react to two White House executive orders designed to accelerate national quantum computing and sensing capabilities, a move the community views as a major validation of the company's strategic alignment with U.S. defense interests. While many participants are actively discussing the potential for a long-term rally and upcoming corporate milestones, some traders remain cautious, highlighting the high volatility and current market pressure impacting the share price.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is facing intense downward pressure following its recent IPO as investors grapple with high valuations, aggressive cash-burning AI initiatives, and fears of significant share dilution upon the expiration of lockup periods. The community remains deeply divided, with vocal bears labeling the stock an overhyped retail trap, while long-term bulls defend the company's visionary growth potential and institutional backing.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is gaining attention as investors closely watch the upcoming maintenance trial results for its weight-loss candidate, VK2735, which remains a key catalyst for potential acquisition or partnership. The community is actively debating the company's prospects for independent commercialization versus a buyout, while keeping a close eye on the competitive landscape within the obesity drug sector.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending following the failure of its Phase 3 SigVig-002 trial for sigvotatug vedotin, a significant setback for the company's oncology pipeline that has investors questioning its growth strategy and leadership. The community is actively debating the future of Pfizer's oncology investments, the impact of recent leadership transitions, and whether the stock's dividend yield justifies holding through the ongoing clinical and structural uncertainty.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is experiencing a sharp sell-off and hitting 52-week lows, driving intense community debate over whether the stock is a broken growth play or a deep-value opportunity. Investors are actively questioning the company's content strategy and lack of share buyback execution while bracing for potential further downside as technical support levels are tested.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Promising Small Cap Stocks To Consider - November 20th

Direxion Daily TSLA Bear 1X Shares, Spring Valley Acquisition, Direxion Daily GOOGL Bull 2X Shares, Safe & Green, Direxion Daily PLTR Bear 1X Shares, Surmodics, and Olema Pharmaceuticals are the...

Surmodics (NASDAQ:SRDX) Sees Unusually-High Trading Volume - Here's What Happened

Surmodics (NASDAQ:SRDX) Sees Strong Trading Volume - Still a Buy...

Best Small Cap Stocks Worth Watching - November 17th

Leap Therapeutics, Spring Valley Acquisition, and Surmodics are the three Small Cap stocks to watch today, according to MarketBeat's stock screener tool. Small-cap stocks are shares of publicly...

Surmodics Target of Unusually High Options Trading (NASDAQ:SRDX)

Surmodics, Inc. (NASDAQ:SRDX - Get Free Report) was the target of some unusual options trading on Monday. Stock investors bought 13,635 call options on the stock. This represents an increase of...

Surmodics (NASDAQ:SRDX) Sets New 52-Week High - Still a Buy?

Surmodics (NASDAQ:SRDX) Sets New 1-Year High - Here's What Happened...

Surmodics Announces FTC Does Not Intend to Appeal Denial of Injunction, Order Preventing Closing Set to Expire Today

Surmodics, Inc. (Nasdaq: SRDX) (Surmodics or the Company), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that it expects to...

Surmodics (NASDAQ:SRDX) Earns Underperform Rating from Barrington Research

Barrington Research downgraded Surmodics from a "market perform" rating to an "underperform" rating in a research report on Friday...

Fortress Biotech (FBIO) Surpasses Q3 Earnings Estimates

Fortress Biotech (FBIO) delivered earnings and revenue surprises of +125.58% and -25.55%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

63,050 Shares in Surmodics, Inc. $SRDX Acquired by Thompson Davis & CO. Inc.

Thompson Davis & CO. Inc. acquired a new stake in Surmodics, Inc. (NASDAQ:SRDX - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and...

TriSalus Life Sciences, Inc. (TLSI) Reports Q3 Loss, Tops Revenue Estimates

TriSalus Life Sciences, Inc. (TLSI) delivered earnings and revenue surprises of -464.71% and +0.79%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Surmodics, Inc. engages in the provision of surface modification technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements. The firm operates through the following segments: Medical Device, In Vitro Diagnostics, and Corporate. The Medical Device segment designs, develops, and manufactures vascular interventional medical devices, surface modification coating technologies, as well as drug-delivery coating technologies. The In Vitro Diagnostics segment is composed of component products and technologies for diagnostic test kits and biomedical research applications. The company was founded in June 1979 and is headquartered in Eden Prairie, MN.

Surmodics, Inc.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$42.98
Prev Close	$42.83
Open	$42.87
Dividend Yield	N/A
50-Day Moving Average	$32.20
Beta	0.63
Avg. Volume	92,646.43
PE Ratio	-34.75

52-Week High	$43.00
52-Week Low	$25.87
Market Capitalization	$614.51M
EPS (Annual)	N/A
Price to Book	5.52
Revenue Per Employee	N/A

Feed

News

Sentiment

Earnings

Fundamentals

Info

SRDXSurmodics, Inc.

Latest SRDX News